Free Trial

Chemomab Therapeutics (CMMB) Insider Trading & Ownership

Chemomab Therapeutics logo
$1.18 +0.03 (+2.61%)
Closing price 07/3/2025 03:33 PM Eastern
Extended Trading
$1.16 -0.01 (-1.27%)
As of 07/3/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemomab Therapeutics (NASDAQ:CMMB) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.91%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$1.89M
Get CMMB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Chemomab Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CMMB Insider Buying and Selling by Quarter

Chemomab Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2023Israel Gp Ltd. OrbimedMajor ShareholderSell336,900$3.58$1,206,102.00  
11/16/2022George Adi MorInsiderSell324,775$2.08$675,532.00  
11/16/2022Neil Harris CohenDirectorSell2,409$2.00$4,818.00  
(Data available from 1/1/2013 forward)

CMMB Insider Trading Activity - Frequently Asked Questions

The list of insiders at Chemomab Therapeutics includes George Adi Mor, Israel Gp Ltd. Orbimed, and Neil Harris Cohen. Learn more on insiders at CMMB.

11.91% of Chemomab Therapeutics stock is owned by insiders. Learn more on CMMB's insider holdings.



This page (NASDAQ:CMMB) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners